Skip to main content
logo
Island Pharmaceuticals Limited (ASX:ILA)
Australia flag Australia · Delayed Price · Currency is AUD
0.4300
+0.0050 (1.18%)
Sep 2, 2026, 12:21 PM AEST

Island Pharmaceuticals Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
12.877.251.6624.79
Cash & Short-Term Investments
12.877.251.6624.79
Cash Growth
77.49%336.76%-16.91%-58.26%-25.90%
Other Receivables
0.290.180.890.020.02
Receivables
0.290.180.890.020.02
Prepaid Expenses
0.10.060.010.030.09
Total Current Assets
13.267.492.562.054.9
Other Intangible Assets
0.74----
Total Assets
147.492.562.054.9

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
0.160.150.310.110.24
Accrued Expenses
0.380.180.30.150.34
Short-Term Debt
--0.42--
Other Current Liabilities
000.0100
Total Current Liabilities
0.540.341.050.260.58
Total Liabilities
0.540.341.050.260.58

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
42.9131.6322.3919.919.9
Retained Earnings
-34.9-25.08-21.2-19.76-4.73
Comprehensive Income & Other
5.440.610.331.65-10.85
Shareholders' Equity
13.467.161.521.794.32
Total Liabilities & Equity
147.492.562.054.9

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
--0.42--
Net Cash (Debt)
12.877.251.2424.79
Net Cash Growth
77.49%485.58%-38.03%-58.26%-25.90%
Net Cash Per Share
0.050.040.010.020.06
Filing Date Shares Outstanding
295.92247.24126.7781.2781.27
Total Common Shares Outstanding
295.92236.09126.7781.2781.27
Working Capital
12.727.161.521.794.32
Book Value Per Share
0.050.030.010.020.05
Tangible Book Value
12.727.161.521.794.32
Tangible Book Value Per Share
0.040.030.010.020.05